In addition, high VEGF expression was significantly associated with ER and PR negative status in familial cancers, and with ER negative status in sporadic cancers, according to Ali, who in an “in vitro” and “in vivo” study demonstrated that a high level of oestrogen may inhibit angiogenic pathways [43]. The gene discussed is VEGFA; the disease is hereditary cancer.